14 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Gainers

• ChemoCentryx, Inc. CCXI shares surged 336.1% to $35.15 during Tuesday's pre-market session. The market value of their outstanding shares is at $501.1 million. The most recent rating by Raymond James, on November 26, is at Strong Buy, with a price target of $56.00.
• InflaRx, Inc. IFRX stock moved upwards by 13.2% to $3.00. The market value of their outstanding shares is at $69.1 million.
• Onconova Therapeutics, Inc. ONTX shares moved upwards by 12.6% to $0.16. The market cap stands at $4.3 million.
• Global Blood Therapeutics, Inc. GBT stock increased by 11.6% to $67.00. The market value of their outstanding shares is at $2.8 billion. The most recent rating by Nomura, on November 26, is at Buy, with a price target of $112.00.
• VBI Vaccines, Inc. VBIV shares moved upwards by 6.8% to $0.73. The market value of their outstanding shares is at $104.2 million. The most recent rating by Raymond James, on November 14, is at Outperform, with a price target of $3.00.
• Mallinckrodt, Inc. MNK shares moved upwards by 5.0% to $3.78. The market cap seems to be at $265.6 million. The most recent rating by Stifel, on September 09, is at Hold, with a price target of $8.00.

Losers

• ASLAN Pharmaceuticals, Inc. ASLN stock plummeted 16.4% to $1.07 during Tuesday's pre-market session. The market cap seems to be at $49.3 million. The most recent rating by H.C. Wainwright, on November 14, is at Buy, with a price target of $2.00.
• Sonoma Pharmaceuticals, Inc. SNOA stock declined 10.2% to $3.70. The market cap seems to be at $8.3 million.
• Kazia Therapeutics, Inc. KZIA shares declined 7.7% to $5.18. The market cap seems to be at $23.9 million.
• Canopy Growth, Inc. CGC shares fell 2.8% to $17.90. The market cap seems to be at $6.9 billion. According to the most recent rating by Bank of America, on November 20, the current rating is at Buy.
• Aurora Cannabis, Inc. ACB stock fell 2.8% to $2.44. The market cap seems to be at $3.6 billion. The most recent rating by Piper Jaffray, on October 22, is at Neutral, with a price target of $4.00.
• Clovis Oncology, Inc. CLVS shares plummeted 2.7% to $9.99. The market value of their outstanding shares is at $173.7 million. The most recent rating by Evercore ISI Group, on November 19, is at In-Line, with a price target of $8.00.
• Genmab, Inc. GMAB shares declined 1.4% to $23.45. The market cap seems to be at $14.1 billion. The most recent rating by HC Wainwright & Co., on October 16, is at Buy, with a price target of $25.00.
• Sorrento Therapeutics, Inc. SRNE stock decreased by 1.0% to $3.08. The market value of their outstanding shares is at $215.6 million. The most recent rating by JMP Securities, on October 07, is at Market Outperform, with a price target of $21.00.